Company Ibere Pharmaceuticals

IBER

KYG468431013

Managers

Members of the board

Share class

Company contact information

Sector

Sector Shell Companies

Inactive Instrument

Ibere Pharmaceuticals is a blank check company. The Company is created for the purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company focuses on healthcare sector. The Company has no operations and has not generated revenues.

Managers	Title	Age	Since
Osagie Imasogie CEO	Chief Executive Officer	62	-
Lisa Gray DFI	Director of Finance/CFO	59	-
Zoltan Kerekes COO	Chief Operating Officer	58	-

Members of the board	Title	Age	Since
Louis J. Vollmer BRD	Director/Board Member	-	-
Osagie Imasogie CEO	Chief Executive Officer	62	-
Elaine Jones BRD	Director/Board Member	69	-
Calvin Johnson BRD	Director/Board Member	57	-
Lisa Gray DFI	Director of Finance/CFO	59	-
Zoltan Kerekes COO	Chief Operating Officer	58	-
Henrietta Ukwu BRD	Director/Board Member	64	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	3,450,000	0	0	80.00 %
Stock B	1	13,800,000	13,800,000 ( 100.00 %)	0

Ibere Pharmaceuticals

2005 Market Street Suite 2030

19103, Philadelphia

http://www.iberepharma.com

Financials

Holding Companies

Holding Companies

Investment Holding Companies

Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+137.37%	5.68B
SCREAMING EAGLE ACQUISITION CORP.	+1.89%	1.01B
CHURCHILL CAPITAL CORP VII	+2.19%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+25.27%	819M
ARES ACQUISITION CORPORATION II	+1.68%	663M
E7 GROUP	+1.80%	610M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+21.31%	552M

Shell Companies